Cipralisant (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Cipralisant" in English language version.

refsWebsite

Global rank English rank

2^nd place

4^th place

11^th place

8^th place

doi.org

Ito S, Yoshimoto R, Miyamoto Y, Mitobe Y, Nakamura T, Ishihara A, et al. (January 2006). "Detailed pharmacological characterization of GT-2331 for the rat histamine H3 receptor". European Journal of Pharmacology. 529 (1–3): 40–46. doi:10.1016/j.ejphar.2005.10.066. PMID 16316645.
Tedford CE, Hoffmann M, Seyedi N, Maruyama R, Levi R, Yates SL, et al. (June 1998). "High antagonist potency of GT-2227 and GT-2331, new histamine H3 receptor antagonists, in two functional models". European Journal of Pharmacology. 351 (3): 307–311. doi:10.1016/S0014-2999(98)00396-3. PMID 9721022.
Krueger KM, Witte DG, Ireland-Denny L, Miller TR, Baranowski JL, Buckner S, et al. (July 2005). "G protein-dependent pharmacology of histamine H3 receptor ligands: evidence for heterogeneous active state receptor conformations". The Journal of Pharmacology and Experimental Therapeutics. 314 (1): 271–281. doi:10.1124/jpet.104.078865. PMID 15821027. S2CID 20470970.
Liu H, Kerdesky FA, Black LA, Fitzgerald M, Henry R, Esbenshade TA, et al. (January 2004). "An efficient multigram synthesis of the potent histamine H3 antagonist GT-2331 and the reassessment of the absolute configuration". The Journal of Organic Chemistry. 69 (1): 192–194. doi:10.1021/jo035264t. PMID 14703397.

Ito S, Yoshimoto R, Miyamoto Y, Mitobe Y, Nakamura T, Ishihara A, et al. (January 2006). "Detailed pharmacological characterization of GT-2331 for the rat histamine H3 receptor". European Journal of Pharmacology. 529 (1–3): 40–46. doi:10.1016/j.ejphar.2005.10.066. PMID 16316645.
Tedford CE, Hoffmann M, Seyedi N, Maruyama R, Levi R, Yates SL, et al. (June 1998). "High antagonist potency of GT-2227 and GT-2331, new histamine H3 receptor antagonists, in two functional models". European Journal of Pharmacology. 351 (3): 307–311. doi:10.1016/S0014-2999(98)00396-3. PMID 9721022.
Krueger KM, Witte DG, Ireland-Denny L, Miller TR, Baranowski JL, Buckner S, et al. (July 2005). "G protein-dependent pharmacology of histamine H3 receptor ligands: evidence for heterogeneous active state receptor conformations". The Journal of Pharmacology and Experimental Therapeutics. 314 (1): 271–281. doi:10.1124/jpet.104.078865. PMID 15821027. S2CID 20470970.
Liu H, Kerdesky FA, Black LA, Fitzgerald M, Henry R, Esbenshade TA, et al. (January 2004). "An efficient multigram synthesis of the potent histamine H3 antagonist GT-2331 and the reassessment of the absolute configuration". The Journal of Organic Chemistry. 69 (1): 192–194. doi:10.1021/jo035264t. PMID 14703397.

Krueger KM, Witte DG, Ireland-Denny L, Miller TR, Baranowski JL, Buckner S, et al. (July 2005). "G protein-dependent pharmacology of histamine H3 receptor ligands: evidence for heterogeneous active state receptor conformations". The Journal of Pharmacology and Experimental Therapeutics. 314 (1): 271–281. doi:10.1124/jpet.104.078865. PMID 15821027. S2CID 20470970.